Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial

Juergen Rech, Koray Tascilar, Melanie Hagen, Arnd Kleyer, Bernhard Manger, Verena Schoenau, Axel J Hueber, Stefan Kleinert, Xenofon Baraliakos, Jürgen Braun, Uta Kiltz, Martin Fleck, Andrea Rubbert-Roth, David M Kofler, Frank Behrens, Martin Feuchtenberger, Michael Zaenker, Reinhard Voll, Nils Venhoff, Jens ThielCornelia Glaser, Eugen Feist, Gerd R Burmester, Kirsten Karberg, Johannes Strunk, Juan D Cañete, Ladislav Senolt, Maria Filkova, Esperanza Naredo, Raquel Largo, Gerhard Krönke, Maria Antonietta D'Agostino, Mikkel Østergaard, Georg Schett

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Lingua originaleEnglish
pagine (da-a)N/A-N/A
RivistaThe Lancet
DOI
Stato di pubblicazionePubblicato - 2024

Keywords

  • Abatacept, rheumatoid arthritis, ARIAA,

Cita questo